$VSTM Company News Stocks to watch Thursday: Green

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$VSTM Company News

Stocks to watch Thursday: Green Mountain, Merck 6:55 a.m. Feb. 2, 2012 - MarketWatch
A busy IPO year as Facebook buzz builds 4:46 p.m. Jan. 30, 2012 - Benjamin Pimentel
Verastem climbs in early post-IPO trading 10:55 a.m. Jan. 27, 2012 - MarketWatch.com

Verastem Initiates Phase 1 Trial of Dual mTOR/PI3K Inhibitor 6:16 a.m. Dec. 10, 2013 - benzinga.com
Verastem (VSTM) in Focus: Stock Rises by 7.3% - Tale of the Tape 9:11 a.m. Dec. 6, 2013 - Zacks.com
Investments On Biotech's Cutting Edge: Joseph Pantginis 4:41 p.m. Nov. 18, 2013 - Seeking Alpha
10-Q: VERASTEM, INC. 7:21 a.m. Nov. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
Should You Follow Insiders On These 3 Stocks? 6:58 p.m. Nov. 4, 2013 - Seeking Alpha
Killing Cancer Stem Cells: The Final Battle? 2:48 p.m. Oct. 27, 2013 - Seeking Alpha
Novel Therapies and Defeating Multi-Drug Resistance Key in Success of Cancer Drug Companies 12:01 p.m. Oct. 23, 2013 - Wall St. Cheat Sheet
Will Galena's Initiatives Translate Into Positive Returns? 4:09 p.m. Sept. 28, 2013 - Seeking Alpha
Verastem Begins Phase 2 Trial of Defatinib in Lunc Cancer 7:37 a.m. Sept. 26, 2013 - benzinga.com
Verastem Initiates Defactinib Trial in Japan 5:04 a.m. Sept. 24, 2013 - benzinga.com
Verastem: An Attractive Long-Term Investment In The Cancer Stem Cell Space 5:12 a.m. Sept. 17, 2013 - Seeking Alpha
Verastem Issued U.S. Patent Covering VS-4718 Composition of Matter 5:01 a.m. Aug. 15, 2013 - benzinga.com
10-Q: VERASTEM, INC. 8:19 a.m. Aug. 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
6 Reasons ImmunoCellular Therapeutics Is One Of The Best Risk Vs. Rewards In The Market 9:00 a.m. Aug. 7, 2013 - Seeking Alpha
6 Oncology-Focused Biotech Growth Engines: Mara Goldstein 5:01 p.m. Aug. 2, 2013 - Seeking Alpha
UPDATE: Jefferies Initiates Verastem at Buy on Cancer Research Potential 7:23 a.m. July 29, 2013 - benzinga.com
Verastem Receives Orphan Drug Designation from the U.S. FDA for Defactinib in Mesothelioma 5:08 a.m. July 24, 2013 - benzinga.com
Verastem Drug Achieves a Complete Response in Platinum-Resistant Ovarian Cancer 5:16 a.m. July 23, 2013 - benzinga.com
Verastem Announces Pricing of Public Offering of Common Stock At $15 7:25 a.m. July 17, 2013 - benzinga.com
Verastem Announces Proposed Public Offering of Common Stock 2:09 p.m. July 16, 2013 - benzinga.com


Financial Results, Conference Presentation Schedule, Clinical Trial Initiation, Recognition, and Dividend Payment - Research Report on Cantel, Chimerix, Verastem, Amedisys, and Ensign Group 8:00 a.m. Dec. 25, 2013 - PR Newswire
Verastem Announces Addition to the NASDAQ Biotechnology Index 7:00 a.m. Dec. 19, 2013 - BusinessWire
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
Verastem Initiates Clinical Trial of Dual mTOR/PI3K Inhibitor 7:00 a.m. Dec. 10, 2013 - BusinessWire
Verastem to Present at Upcoming Conferences 7:00 a.m. Nov. 26, 2013 - BusinessWire
Verastem Reports Third Quarter 2013 Financial and Corporate Results 7:00 a.m. Nov. 12, 2013 - BusinessWire
Verastem Names Jose Baselga, M.D., Ph.D. as Senior Medical Advisor 6:00 a.m. Oct. 31, 2013 - BusinessWire
Verastem Announces Presentations at the 2013 World Conference on Lung Cancer 6:00 a.m. Oct. 24, 2013 - BusinessWire
Verastem Announces Presentation of VS-6063 Clinical and Preclinical Study Results at the 2013 AACR-NCI-EORTC International Conference 6:00 a.m. Oct. 21, 2013 - BusinessWire
Verastem Executives Featured at Boston-Area Biotechnology Events 6:00 a.m. Oct. 15, 2013 - BusinessWire
Verastem Announces Presentations at the 2013 AACR-NCI-EORTC International Conference 6:00 a.m. Oct. 10, 2013 - BusinessWire
Verastem Initiates Phase 2 Trial of Defactinib in Lung Cancer 8:36 a.m. Sept. 26, 2013 - BusinessWire
Verastem Initiates Trial of Defactinib in Japan 6:00 a.m. Sept. 24, 2013 - BusinessWire
Verastem Reports on Ongoing Trials at Cancer Advance at Harvard Medical School 3:00 p.m. Sept. 19, 2013 - BusinessWire
Verastem to Present at Upcoming Scientific and Investor Conferences 6:00 a.m. Sept. 18, 2013 - BusinessWire
Veristat to Assist on Adaptive Enrichment Trial for Verastem's Defactinib in Mesothelioma 4:12 p.m. Sept. 10, 2013 - BusinessWire
Verastem Initiates COMMAND: A Registration-Directed Trial of Defactinib in Patients with Mesothelioma 6:00 a.m. Sept. 10, 2013 - BusinessWire
Verastem to Present at Upcoming Conferences 6:00 a.m. Sept. 3, 2013 - BusinessWire
Verastem Issued U.S. Patent Covering VS-4718 Composition of Matter 6:00 a.m. Aug. 15, 2013 - BusinessWire
Verastem Reports Second Quarter 2013 Financial and Corporate Results 6:00 a.m. Aug. 13, 2013 - BusinessWire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 282

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 308

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 243

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 281

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 462

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 303

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 421

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 594

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 547

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 505

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading

Top 5 Most Recently Viewed Articles

FTI Consulting Set to Announce First Quarter 2025 Results

Updated Category News Views 203

FTI Consulting Plans Earnings Release for First Quarter 2025 FTI Consulting, Inc. (NYSE: FCN) has announced plans to unveil its financial performance for the first quarter concluding March 31, 2025. This event is scheduled for Thursday, April 24, 2025, prior to the commencement of trading on the New York Stock Exchange. The company's leadership will host a conference call...

Continue Reading
Middlefield Canadian Income PCC Reveals Latest Net Asset Value

Updated Category News Views 97

Understanding Middlefield Canadian Income PCC Middlefield Canadian Income PCC is a notable protected cell company established in Jersey. This organization is dedicated to offering investors a consistent income stream originating from its diverse portfolio of investments. Latest Net Asset Value As of the latest update, the estimated Net Asset Value per share stands at...

Continue Reading
Exploring the Future of Ethernet PHY Chips and Their Growth

Updated Category News Views 152

Ethernet PHY Chips Market Overview The Ethernet PHY Chips Market is poised for significant growth, with projections estimating a size of USD 15.2 billion by the end of the next decade. It was valued at approximately USD 3.6 billion in recent years, highlighting a robust expansion trend. Driving Forces Behind Market Expansion As industries increasingly prioritize reliable...

Continue Reading
M/I Homes Achieves Record Performance for Q3 2024

Updated Category News Views 119

Strong Q3 2024 Performance by M/I Homes, Inc. M/I Homes, Inc. (NYSE: MHO) has recently announced its impressive results for the third quarter of 2024, showcasing its continued strength and growth in the homebuilding sector. The company reported record figures in several key areas, further solidifying its position as a leading homebuilder in the United States. Record Homes...

Continue Reading
Transforming Game Advertising: Frameplay and iion Unite

Updated Category News Views 207

Transformative Partnership in Game Advertising Two industry leaders, Frameplay and iion, have joined forces to reshape the landscape of in-game advertising, creating an expansive platform that revolutionizes the way advertisers and publishers connect. This strategic partnership aims to deliver exceptional scale and reach in key markets, fundamentally changing the...

Continue Reading